quantisnow
FeedTopReportsPricing
⌘K
Live feed
14:44:06·1308d
NEWSRelease
Avenue Therapeutics Inc. logo
Biohaven Ltd. logo
Invest Green Acquisition Corporation logo
+1

Stocks That Hit 52-Week Highs On Friday

ATXI· Avenue Therapeutics Inc.BHVN· Biohaven Ltd.IGAC· Invest Green Acquisition CorporationNOAC· Natural Order Acquisition Corp.
Health CareFinanceIndustrials
Original source

Companies

  • ATXI
    Avenue Therapeutics Inc.
    Health Care
  • BHVN
    Biohaven Ltd.
    Health Care
  • IGAC
    Invest Green Acquisition Corporation
    Finance
  • NOAC
    Natural Order Acquisition Corp.
    Industrials

Recent analyst ratings

  • Apr 13BHVNUpdateCanaccord Genuity$21.00
  • Feb 6BHVNUpdateGoldman$23.00
  • Jan 21BHVNUpdateRBC Capital Mkts$22.00
  • Dec 3BHVNUpdateH.C. Wainwright$11.00
  • Nov 26BHVNUpdateUBS$11.00
  • Nov 6BHVNUpdateBernstein$9.00

Related

  • ANALYST10d
    Canaccord Genuity initiated coverage on Biohaven with a new price target
  • SEC24d
    SEC Form 10-K filed by Invest Green Acquisition Corporation
  • SEC24d
    SEC Form 10-K filed by Avenue Therapeutics Inc.
  • INSIDER35d
    SEC Form 4 filed by Mehta Kishan
  • PR35d
    Biohaven's Phase 2 Obesity Study with Taldefgrobep Alfa, a Novel Myostatin-Activin Pathway Inhibitor, Completes Enrollment
  • SEC41d
    SEC Form DEFA14A filed by Biohaven Ltd.
  • SEC41d
    SEC Form DEF 14A filed by Biohaven Ltd.
  • INSIDER45d
    Amendment: Director Childs John W bought $864,115 worth of shares (28,400 units at $30.43) (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022